TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Headache NRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRPF z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPRS at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPRS with mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with tramadol requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Minimal Clinically Important Difference (MCID) in OMAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ENC knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in ImP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived need for surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of skin rash
Endpoint domain: Adverse events/effects
Primary endpoint: Median time-to-remission of first incidence of rash
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Maximum grade incidence of rash
Endpoint domain: Adverse events/effects
Primary endpoint: Reported impacts on oral health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AFC improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: client-rated facilitators and barriers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent heavy drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modification of midwall fractional shortening over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall accuracy of classification between normal and stressed trials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occupational pressure score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduced internalising problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Days to regain birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of 5-yearly screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean time to peak sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to peak motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEP questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schramek questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in white blood cell and lymphocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase in apoptotic markers (ccK18 and Apo1-Fas)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in antiapoptotic protein Survivin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of inflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in TAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced denture biofilm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced Candida spp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced S mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB-BMD or fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean number of choices to obtain the correct solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liver enzyme elevations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year death or rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Therapeutic inertia (TI) as measured by pupil dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of first off-bed activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction of pain control or pain relief
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: peak net forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative forefoot forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain scores for capillary self-sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful collection of capillary blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net promoter score for capillary blood sampling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: tonic cold pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concurrent validity for ReVeRe.D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days with mechanical ventilation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Montgomery‐Asberg Depression Rating Scale score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cormack and Lehane grade of larynx visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of vocal cord haematoma
Endpoint domain: Adverse events/effects
Primary endpoint: HCV treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy for detecting AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal indexes (PLI, BI, PD, PAL, alveolar bone height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF‐α and IL‐6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Successful outcome at six months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in cervicogenic headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spirometric PIF ≥30 L/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total HEI-2015 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Workload levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depersonalization levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased supporter involvement in diabetes self-management
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Increased use of autonomy supportive communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased satisfaction with health system support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean concentrations of VEGF in aqueous humor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTGF/log10 (VEGF) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pain hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Funding adequacy for IICTs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Stroke within 1 year of diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: peri-operative narcotic requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen Desaturation Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Site-specific tenderness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving 75% improvement in Psoriasis Area and Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving 90% improvement in Psoriasis Area and Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Physician’s Global Assessment score of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biopsy-proven rejection within 12 months posttransplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on the Face-name association test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased memorization of the content of Conversations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant improvements in psychological well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lymphocele development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean drainage days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Amount of drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Burden of Illness (BI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak isometric, concentric and eccentric quadriceps muscle torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in frequency and severity of PTSD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in PTSD-related symptoms (depression, anxiety, rumination, quality of life)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median time from recurrence to death
Endpoint domain: Mortality/survival
Primary endpoint: serious clinical adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: discontinuation for virological failure
Endpoint domain: Adverse events/effects
Primary endpoint: Cancer-related fatigue (CRF) symptoms relief
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: COVID-19 vaccination intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fatigue scores reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Aerobic capacity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Use of modern contraceptives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of LARC methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of plasma IL‐1, IL‐6, and TNF‐α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: WIDEA-FS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: epilepsy risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: CIED infection risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PSPDR (Polyp Surveillance and Detection Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unintended pregnancy rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Understanding of risks and outcomes of ECC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seroconversion rate of poliovirus types 1, 2 and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of solicited and unsolicited adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Median time to DAS28(CRP) <2.6/≤3.2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of CDAI remission/LDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total time spent in a lower disease state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in GAIS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency of hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: child adjustment problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prosocial skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Median number of medication changes per person
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: displacement at the fracture site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stability in bending testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of BCC
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of timely follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of SpO2 <75%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in neurobehavior and quality of general movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl‐Meyer Motor Scale score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SNIP (Sniff Nasal Inspiratory Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: INR values in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of abdominal distension
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment outcomes of TMJ internal derangement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new bone height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of mother-infant pairs in HIV care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ≥25% HAMD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calcium/creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Human biting rates (HBR) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Malaria infections hazard rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Onset of suicidal ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uptake of PMTCT services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safe sleep practices
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: IGF-1 reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: IGF1:IGFBP3 molar ratio reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cross‐sectional area (CSA) of the right SCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus handicap inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6MWD‐MID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGRQ‐MID
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BI knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Impact and clarity ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: third-party disability (SOS-HEAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proxy report (IOI-HA-SO item 'use')
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: third-party disability (IOI-HA-SO items 'satisfaction' and 'quality of life')
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Achieving cDAPSA treatment targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dribbling speed performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montgomery-Åsberg Depression Rating Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Misorientation after 20 min of wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Horizontal misalignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delayed-recall memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of SpO2 < 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: poor functional outcome (mRS ≥ 4)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Crepitus incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of vaccine reminders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MI adherence rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of pancreatic beta cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: uOC/cOC index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: early postprocedural success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle microvascular blood flow (MBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma insulin improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participation in RCTs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in cannabis-related problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute changes in distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of operative delivery
Endpoint domain: Adverse events/effects
Primary endpoint: attachment level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHOQOL‐BREF score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of CTN injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life affected by altered taste
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: QuickDASH score after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PRWHE score after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-5L index score at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: current rumination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of glaucoma surgeries
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average productivity (appointments per hour)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Value stream duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of complications (posterior wall puncture and haematoma formation)
Endpoint domain: Adverse events/effects
Primary endpoint: Type of food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child resistance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Co-parent support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Awareness of social health insurance scheme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Importance of social health insurance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desire to renew health insurance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ≥50% seizure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: median seizure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: coronal linear deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apical linear deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes